Developing preclinical models of neuroblastoma: driving therapeutic testing
Abstract Despite advances in cancer therapeutics, particularly in the area of immuno-oncology, successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common cancer in infants under 1 year of age, and accounts for approximately 10% of all pediatric cancers. Currently, children...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-12-01
|
| Series: | BMC Biomedical Engineering |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42490-019-0034-8 |